Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 18, 2022

SELL
$63.83 - $80.0 $181,532 - $227,520
-2,844 Closed
0 $0
Q1 2022

May 09, 2022

SELL
$76.85 - $89.45 $27,665 - $32,202
-360 Reduced 11.24%
2,844 $221,000
Q4 2021

Jan 28, 2022

SELL
$74.57 - $87.19 $7,009 - $8,195
-94 Reduced 2.85%
3,204 $275,000
Q3 2021

Oct 27, 2021

SELL
$73.77 - $83.61 $18,368 - $20,818
-249 Reduced 7.02%
3,298 $265,000
Q2 2021

Aug 10, 2021

BUY
$80.5 - $88.01 $33,729 - $36,876
419 Added 13.4%
3,547 $286,000
Q1 2021

May 06, 2021

BUY
$76.38 - $86.03 $46,668 - $52,564
611 Added 24.27%
3,128 $264,000
Q4 2020

Feb 04, 2021

SELL
$75.39 - $82.36 $5,880 - $6,424
-78 Reduced 3.01%
2,517 $202,000
Q3 2020

Oct 28, 2020

SELL
$78.33 - $90.73 $8,929 - $10,343
-114 Reduced 4.21%
2,595 $209,000
Q1 2020

Apr 27, 2020

SELL
$71.57 - $93.3 $25,979 - $33,867
-363 Reduced 11.82%
2,709 $220,000
Q4 2019

Jan 15, 2020

SELL
$76.7 - $88.45 $30,680 - $35,380
-400 Reduced 11.52%
3,072 $257,000
Q3 2019

Nov 08, 2019

SELL
$81.4 - $89.78 $19,536 - $21,547
-240 Reduced 6.47%
3,472 $304,000
Q2 2019

Aug 07, 2019

SELL
$73.44 - $82.41 $5,875 - $6,592
-80 Reduced 2.11%
3,712 $303,000
Q1 2019

May 08, 2019

BUY
$64.48 - $81.31 $7,092 - $8,944
110 Added 2.99%
3,792 $308,000
Q4 2018

Feb 14, 2019

BUY
$61.45 - $77.8 $34,412 - $43,568
560 Added 17.94%
3,682 $242,000
Q3 2018

Nov 13, 2018

SELL
$70.71 - $77.75 $2,262 - $2,488
-32 Reduced 1.01%
3,122 $241,000
Q2 2018

Aug 13, 2018

SELL
$63.43 - $75.41 $20,805 - $24,734
-328 Reduced 9.42%
3,154 $233,000
Q1 2018

May 15, 2018

BUY
$62.56 - $72.26 $2,001 - $2,312
32 Added 0.93%
3,482 $226,000
Q4 2017

Feb 09, 2018

SELL
$61.45 - $66.05 $20,831 - $22,390
-339 Reduced 8.95%
3,450 $223,000
Q3 2017

Oct 19, 2017

BUY
$59.5 - $64.61 $225,445 - $244,807
3,789
3,789 $238,000

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $16.7B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Avantax Planning Partners, Inc. Portfolio

Follow Avantax Planning Partners, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avantax Planning Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Avantax Planning Partners, Inc. with notifications on news.